No Data
Shandong Jincheng Pharmaceutical Group (300233.SZ): The terminal formulation product Oseltamivir phosphate can be used to treat or prevent influenza A and B.
On January 6, 2023, Gelonghui reported that Shandong Jincheng Pharmaceutical Group (300233.SZ) stated on the investor interaction platform that the company produces and sells Oseltamivir phosphate Active Pharmaceutical Ingredient. Its terminal formulation product Oseltamivir phosphate can be used for the treatment or prevention of Influenza A and B.
Express News | Shandong Jincheng Pharmaceutical Group: The company produces and sells Active Pharmaceutical Ingredient Oseltamivir.
Shandong Jincheng Pharmaceutical Group (300233.SZ): Currently, the company's astaxanthin products are mainly applied in fields such as aquaculture and agricultural fertilizers.
On December 23, Glonghui reported that Shandong Jincheng Pharmaceutical Group (300233.SZ) stated on the investor interaction platform that its astaxanthin products are currently mainly applied in fields such as aquaculture and fertilizers.
Express News | Shandong Jincheng Pharmaceutical Group: Subsidiary Jincheng Jinsu has received the approval notification for the supplementary Pharmaceutical application.
Express News | Shandong Jincheng Pharmaceutical Group: The subsidiary's injectable cefoperazone sodium and sulbactam sodium have been approved.
Express News | shandong jincheng pharmaceutical group: Subsidiary obtained Russia GMP certificate
No Data
